Artículos por temáticas

Advances in Autophagy-Lysosomal Pathway and Neurodegeneration via Brain-Gut Axis

Yao P, Han H.

Biomedicines. 2025 Jun 5;13(6):1390. doi: 10.3390/biomedicines13061390.

Nicotine Attenuates Pathogenesis of Parkinson's Disease via α7-nAChR-Mediated Lipid Metabolic Reprogramming and Anti-inflammatory Signaling

Yang J, Li Y, Wang H, Li X, Chen H, Hou H, Hu Q.

Mol Neurobiol. 2025 Jun 9. doi: 10.1007/s12035-025-05124-9. Online ahead of print.

Psychometric properties of outcome measures for freezing of gait in Parkinson's disease: a systematic review and meta-analysis

Proietti P, Ruotolo I, Carlizza A, Ugolini A, Galeoto G, Fabbrini G, Sellitto G.

Expert Rev Pharmacoecon Outcomes Res. 2025 Jun;25(5):647-659. doi: 10.1080/14737167.2025.2477473. Epub 2025 Mar 13.

[Dementia with Lewy Bodies: From a Psychiatric Perspective]

Ikeda M.

Brain Nerve. 2025 Jun;77(6):667-671. doi: 10.11477/mf.188160960770060667.

Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases

Prajapati JL, Dhurandhar Y, Singh AP, Gupta DK, Baghel VS, Kushwaha U, Namdeo KP.

Expert Opin Drug Deliv. 2025 Jun;22(6):805-822. doi: 10.1080/17425247.2025.2489558. Epub 2025 Apr 10.

Unveiling mysteries of aging: the potential of melatonin in preventing neurodegenerative diseases in older adults

Unal O, Akgun-Unal N, Baltaci AK.

Biogerontology. 2025 Jun 24;26(4):125. doi: 10.1007/s10522-025-10254-7.

Standardized clinical assessments and advanced AI-driven instruments used to evaluate neurofunctional deficits, including within biomarker based framework, in Parkinson's disease - human intelligence made vs. AI models - systematic review

Anghelescu A, Munteanu C, Spinu A, Ciobanu V, Popescu C, Cioca IE, Andone I, Stoica SI, Mandu M, Rebedea A, Giuvara S, Malaelea AD, Vladulescu-Trandafir AI, Morcov MV, Onose G.

Front Med (Lausanne). 2025 Jun 13;12:1565275. doi: 10.3389/fmed.2025.1565275. eCollection 2025.

Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases

Drewes N, Fang X, Gupta N, Nie D.

Biomedicines. 2025 Jun 8;13(6):1409. doi: 10.3390/biomedicines13061409.

The highs and lows of monoamine oxidase as molecular target in cancer: an updated review

Hâncu IM, Giuchici S, Furdui-Lința AV, Lolescu B, Sturza A, Muntean DM, Dănilă MD, Lighezan R.

Mol Cell Biochem. 2025 Jun;480(6):3225-3252. doi: 10.1007/s11010-024-05192-w. Epub 2024 Dec 23.

Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons

Sidhu RK, Maparu K, Singh S, Aran KR.

Pharmacol Rep. 2025 Jun;77(3):576-592. doi: 10.1007/s43440-025-00717-6. Epub 2025 Mar 21.

Broken Balance: Emerging Cross-Talk Between Proteostasis and Lipostasis in Neurodegenerative Diseases

Tittelmeier J, Nussbaum-Krammer C.

Cells. 2025 Jun 4;14(11):845. doi: 10.3390/cells14110845.

New Perspectives on Parkinson's Disease Subtyping: A Narrative Review

Buchmann C, Bouchard M.

Can J Neurol Sci. 2025 May 30:1-28. doi: 10.1017/cjn.2025.10134. Online ahead of print.

RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases-advantages and limitations

Koníčková D, Hraboš D, Menšíková K, Tučková L, Kaleta M, Strnad M, Colosimo C, Kaňovský P.

Front Neurol. 2025 May 27;16:1578252. doi: 10.3389/fneur.2025.1578252. eCollection 2025.

Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment

Zawar I, Quigg M, Johnson EL, Ghosal S, Manning C, Kapur J.

JAMA Neurol. 2025 Jun 1;82(6):605-613. doi: 10.1001/jamaneurol.2025.0552.

4-meter walk test in patients with Parkinson's disease: A reliability and validity study

Ozkan T, Soke F, Erkoc Ataoglu NE, Karakoc S, Gulsen C, Kocer B, Comoglu SS, Kaplan F, Tokcaer Bora HA.

Gait Posture. 2025 Jun;119:87-92. doi: 10.1016/j.gaitpost.2025.02.019. Epub 2025 Mar 5.